申请人:Ube Industries, Ltd.
公开号:EP2025676A1
公开(公告)日:2009-02-18
An object of the present invention is to create a novel indazole derivative having a spiro ring structure in a side chain, which is useful as a pharmaceutical, and to find a new pharmacological activity of the derivative. The present invention compound is represented by the general formula [I] and has an excellent Rho kinase inhibitory activity. In the formula, the ring X represents a benzene ring or a pyridine ring; R1 and R2 represent halogen, H, OH, alkoxy, cycloalkyloxy, aryloxy, alkyl, cycloalkyl or the like; R3 represents halogen, H or the like; R4 and R5 represent halogen, H or the like; R6 and R7 represent H, alkyl or the like; and m, n, p and q represent an integer of 0 to 3. In this connection, each group may have a substituent.
本发明的目的是创造一种侧链具有螺环结构的新型吲唑衍生物,该衍生物可用作药物,并寻找该衍生物的新药理活性。本发明化合物由通式[I]表示,具有优异的 Rho 激酶抑制活性。式中,环 X 代表苯环或吡啶环;R1 和 R2 代表卤素、H、OH、烷氧基、环烷氧基、芳氧基、烷基、环烷基或类似物;R3 代表卤素、H 或类似物;R4 和 R5 代表卤素、H 或类似物;R6 和 R7 代表 H、烷基或类似物;m、n、p 和 q 代表 0 至 3 的整数。